1. The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma. (13th December 2018) Authors: Graf, N.P.; Koelblinger, P.; Galliker, N.; Conrad, S.; Barysch, M.; Mangana, J.; Dummer, R.; Cheng, P.F.; Goldinger, S.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗